Where is Xogene located?

Xogene is headquartered in United Kingdom. It is registered at Plot 838 Sector 38, Gurgaon, Gurugram, Haryana, India, 122001.

How many employees does Xogene have?

As of Apr 30, 2026, the latest employee count at Xogene is 114.

Is Xogene a funded company?

Xogene is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Xogene rank among its competitors?

Xogene ranks 47th amongst 552 active competitors, of which 3 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Medicus Pharma, which secured $11M in May, 2024.

Who are the top competitors of Xogene?

Xogene's top competitors include PPD, Kayentis and Cambrian BioPharma. Among them, Medicus Pharma secured the most recent funding round in May, 2024.

Xogene - 2026 Company Profile & Competitors

Xogene is an unfunded company based in United Kingdom, founded in 2010. It operates as a Provider of clinical trial transparency solutions and related advisory services. Xogene has not raised any funding yet. The company has 552 active competitors, including 3 funded and 23 that have exited. Its top competitors include companies like PPD, Kayentis and Cambrian BioPharma.

Company Details

Provider of clinical trial transparency solutions and related advisory services. The company offers platforms streamlining disclosure workflows and automating complex processes. Services include clinical trial transparency and disclosure, advisory services, and medical writing. Redaction and anonymization services protect sensitive clinical information while maintaining data utility.

Website: www.xogene.com
Registered Address: Plot 838 Sector 38, Gurgaon, Gurugram, Haryana, India, 122001

Key Metrics

Founded Year

2010

Location

United Kingdom

Stage

Unfunded

Ranked

47^th among 552 active competitors

Employee Count

114 as on Apr 30, 2026

Similar Companies

PPD & 553 more

View Xogene's full profile

Xogene is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
XOGENE SOLUTIONS PRIVATE LIMITED CIN: U74999HR2017FTC067805 , India, Active	Feb 21, 2017	$1M - $10M (As on Mar 31, 2025)	-

Xogene has not raised any funding rounds yet.

Xogene's employee count trend

Xogene has 114 employees as of Apr 26. Here is Xogene's employee count trend over the years:

Uncover Xogene's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Xogene include PPD, Kayentis and Cambrian BioPharma. Here is the list of Top 10 competitors of Xogene, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PPD 1985, Wilmington (United States), Acquired	CRO providing diversified clinical development services	-	The Carlyle Group, HHS	64/100
2nd	Kayentis 2003, Meylan (France), Series D	Provider of electronic clinical outcome assessment solutions for clinical trials	$36.2M	Extens, XAnge & 5 others	58/100
3rd	Cambrian BioPharma 2019, Brooklyn (United States), Series C	Developer of medicines and therapies	$211M	Future Ventures, Apeiron Investment Group ... & 20 others	48/100
4th	Symphony Health 2012, Horsham (United States), Acquired	Provider of clinical research, consulting, and commercial services for healthcare sectors	-	Autonomy Ventures, STG	42/100
5th	Medicus Pharma 2008, Toronto (Canada), Public	Clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies in the biotechnology and life sciences industry	-	-	42/100
6th	H.U. Group Holdings 1950, Shinjuku (Japan), Public	Provider of clinical testing, diagnostics, and healthcare services. This entity offers a range of services encompassing laboratory testing and related services, in-vitro diagnostics, healthcare-related services, and research and development. Their activities include supporting research in clinical laboratory medicine, fostering technological advancements, and contributing to the overall progress of medical science and healthcare technology. They also engage in intellectual property activities and have initiatives addressing public health concerns.	-	-	42/100
7th	Hangzhou Baicheng Pharmaceutical Technology 2011, Hangzhou (China), Public	Provider of comprehensive pharmaceutical research and development services across drug lifecycles	-	Paradise Silicon Valley Asset Management Group	36/100
8th	Peachtree BioResearch Solutions 2008, Marietta (United States), Unfunded	Provider of clinical research services for biotechnology, pharmaceutical, and medical device companies	-	-	36/100
9th	YD Biopharma 2004, Taipei (Taiwan), Unfunded	Provider of diagnostic and therapeutic technologies, focusing on exosome science and cancer detection	-	-	34/100
10th	IPHARMA 2012, Moscow (Russia), Unfunded	CRO focused on conducting all drug clinical trials	-	-	31/100
47th	Xogene 2010, United Kingdom, Unfunded	Provider of clinical trial transparency solutions and related advisory services	-	-	22/100